Cancers once primarily associated with older adults are increasingly being detected in people under 50, sparking debate over whether the trend reflects a genuine rise in disease or improved detection methods.
A U.S. government study published earlier this year reviewed more than two million cancer cases diagnosed in individuals aged 15 to 49 between 2010 and 2019. It found that out of 33 cancer types, 14 showed higher incidence in at least one younger age group, with women accounting for nearly two-thirds of early-onset cases.
But a new study published in JAMA Internal Medicine suggests that much of the apparent increase may be attributed to overdiagnosis rather than a true rise in life-threatening cancers. Researchers examined eight cancer types with the fastest-growing incidence in younger adults — including thyroid, anus, kidney, small intestine, colorectal, endometrial, pancreas and myeloma — and compared diagnosis trends with mortality rates.
Their findings showed that while diagnoses of these cancers have roughly doubled since 1992, death rates have remained relatively stable. For cancers such as thyroid and kidney, incidence has climbed sharply, yet mortality has not, suggesting many detected cases may never have caused harm if left undiscovered.
A similar pattern has emerged with breast cancer in women under 50. Although early-stage diagnoses have risen, mortality has halved over the past three decades, thanks largely to advances in treatment rather than a surge in aggressive disease.
There are, however, important exceptions. Colorectal and endometrial cancers have shown modest but consistent increases in mortality, pointing to a genuine rise in dangerous disease. Experts say factors such as rising obesity rates and declining hysterectomy procedures, which once reduced endometrial cancer risk, may be driving the trend.
For most other cancers, the researchers argue, the apparent rise is being fuelled by more widespread use of imaging, screening, and incidental findings during unrelated medical tests. These advances allow doctors to detect tumours earlier, but in many cases the cancers identified are unlikely to progress to life-threatening illness.
The study’s authors caution against framing early-onset cancer as an epidemic. They warn that unnecessary diagnoses can create heavy emotional, physical, and financial burdens, exposing otherwise healthy young adults to invasive treatments and long-term monitoring for cancers that might never have caused harm.
“Overdiagnosis can carry serious consequences,” the researchers noted, adding that the focus should be on distinguishing between aggressive cancers that require intervention and indolent ones that do not.
The debate underscores the delicate balance facing modern medicine: while earlier detection can save lives, increasingly sensitive diagnostic tools also risk inflating cancer statistics and leading to overtreatment.
